News
The drugmaker has become a clear winner with its weight-loss drugs. Now, with a pill under development, the company should ...
Insurers are cutting coverage, citing costs. But there’s seldom any discussion of the return on investment from these drugs ...
Filipino naturopathy practitioner Arturo Arboleda, also known as Doc Atoie, denies endorsing the herbal foot patch that ...
Senior Advocate Diya Kapur, representing the petitioner, informed the court that some gyms were promoting these drugs as a ...
The Delhi High Court on Tuesday disposed of a public interest litigation (PIL) raising alarm over the off-label and ...
This discovery could make treatment for an eye disease affecting millions with diabetes more accessible and affordable.
7don MSN
Jamun seed powder, derived from the Indian blackberry, has been used in Ayurvedic medicine for blood sugar control. Rich in jamboline and jambosine, i ...
High emotional demands and confrontations in person-contact jobs raise the risk for type 2 diabetes, with the risk growing ...
Ozempic, or semaglutide, is an anti-diabetic medication primarily used to treat type 2 diabetes. However, people have recognised its effectiveness in reducing weight, especially in obese people ...
Diabetes is a leading cause of vision loss in the United States, and cataracts are a common complication of the disease. With ...
Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes ...
18d
News-Medical.Net on MSNDiabetes drug semaglutide shows promise in reducing dementia riskResearchers at the Case Western Reserve School of Medicine have found that semaglutide, a popular diabetes and weight-loss drug, may lower the risk of dementia in people with type 2 diabetes (T2D).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results